Lexington Biosciences, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 28, 2019 at 05:57 pm EST
Lexington Biosciences, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced net loss was CAD 101,025 compared to CAD 563,192 a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.15 a year ago. For the nine months, net loss was CAD 431,350 compared to CAD 2.088 million a year ago. Basic loss per share from continuing operations was CAD 0.11 compared to CAD 0.55 a year ago.